Quote | Super Quote
14111 SGALIBA@EP2406A (PUT)
RT Nominal down0.082 -0.018 (-18.000%)

18/01/2021 11:04

China Lit (00772) to sell shares of Lanren to Tencent unit

[ET Net News Agency, 18 January 2021] China Literature Limited (00772) said its
subsidiary Tianjin Yuewen and the other vendors have agreed to sell 39.8821% and 60.1179%
of the equity interest of the target, respectively, and TME Subsidiary (a subsidiary of
Tencent) has conditionally agreed to acquire 100% equity interest of the target at the
aggregate consideration of RMB2.7 billion, of which RMB1.077 billion is payable to Tianjin
Yuewen in cash.
The target is Shenzhen Lanren Online Technology Co., Ltd. It is principally engaged in
the business of production, distribution and online broadcasting of podcasts, audiobooks
and other interactive audio entertainment formats. (RC)

Remark: Real time quote last updated: 24/04/2024 11:23
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.